165
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

, , , , &
Pages 533-553 | Published online: 24 Dec 2022

References

  • AbdollahiMCushmanMRosendaalFRObesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive useThromb Haemost200389349349812624633
  • AgraharkarMIsaacsonSMendelssohnDPercutaneously inserted silastic jugular hemodialysis catheters seldom cause jugular vein thrombosisASAIO J19954121691727640421
  • AlikhanRCohenATCombeSRisk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX StudyArch Intern Med2004164996396815136304
  • AlikhanRCohenATCombeSPrevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX studyBlood Coagul Fibrinolysis200314434134612945875
  • AndersonFAJrWheelerHBGoldbergRJThe prevalence of risk factors for venous thromboembolism among hospital patientsArch Intern Med19921528166016641497399
  • AndersonFAJrWheelerHBGoldbergRJA population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT StudyArch Intern Med199115159339382025141
  • AznarJVayaAEstellesARisk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptivesHaematologica200085121271127611114134
  • BalestreriLDeCMMatovicMCentral venous catheter-related thrombosis in clinically asymptomatic oncologic patients: a phlebographic studyEur J Radiol19952021081117588863
  • BathPMIddendenRBathFJLow-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trialsStroke20003171770177810884486
  • BeenenLvanLRDeenikBThe incidence of subclavian vein stenosis using silicone catheters for hemodialysisArtif Organs19941842892928024477
  • BelchJJLoweGDWardAGPrevention of deep vein thrombosis in medical patients by low-dose heparinScott Med J19812621151177291971
  • BellomoRAtkinsRCMembranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted?Nephron19936332492548446259
  • BellomoRWoodCWagnerIIdiopathic membranous nephropathy in an Australian population: the incidence of thromboembolism and its impact on the natural historyNephron19936322402418450923
  • BennettWMLetter: Renal vein thrombosis in nephrotic syndromeAnn Intern Med19758345775781166998
  • BergmannJFNeuhartEA multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study GroupThromb Haemost19967645295348902991
  • BernsteinCNBlanchardJFHoustonDSThe incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatary bowel disease: a population-based cohort studyThromb Haemost20018543043411307809
  • BernMMLokichJJWallachSRVery low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trialAnn Intern Med199011264234282178534
  • BlaszykHWollanPCWitkiewiczAKDeath from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factorsVirchows Arch1999434652953210394888
  • Blomstrom-LundqvistCScheinmanMMAliotEMACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Circulation2003108151871190914557344
  • BoeerAVothEHenzeTEarly heparin therapy in patients with spontaneous intracerebral haemorrhageJ Neurol Neurosurg Psychiatry19915454664671865215
  • BonifacjCQuereIDupuyCCase control studies of the risk factors for deep-vein thrombosis in an adult population hospitalized in internal medicineRev Epidemiol Sante Publique19974564654739496577
  • BozzettiFScarpaDTernoGSubclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patientsJPEN J Parenter Enteral Nutr1983765605626418913
  • BrismarBHardstedtCJacobsonSDiagnosis of thrombosis by catheter phlebography after prolonged central venous catheterizationAnn Surg198119467797837305496
  • BrownKLuddingtonRWilliamsonDRisk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin geneBr J Haematol19979849079099326187
  • BucciarelliPRosendaalFRTripodiARisk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family studyArterioscler Thromb Vasc Biol19991941026103310195932
  • BussaniRCosattiCPulmonary embolism: epidemiologic analysis of 27,410 autopsies during a 10-year periodMedicina (Firenze)199010140432381281
  • CadeJFHigh risk of the critically ill for venous thromboembolismCrit Care Med19821074484507044682
  • CasserlyLFDemberLMThrombosis in end-stage renal diseaseSemin Dial200316324525612753687
  • ChastreJCornudFBouchamaAThrombosis as a complication of pulmonary-artery catheterization via the internal jugular vein: prospective evaluation by phlebographyN Engl J Med198230652782817054699
  • ClarkDDAlbinaJEChazanJASubclavian vein stenosis and thrombosis: a potential serious complication in chronic hemodialysis patientsAm J Kidney Dis19901532652682305766
  • CogoABernardiEPrandoniPAcquired risk factors for deep-vein thrombosis in symptomatic outpatientsArch Intern Med199415421641688285811
  • CohenAQuinlanDPEP trial. Pulmonary Embolism PreventionLancet20003569225247110963215
  • CohenATDavidsonBLGallusASEfficacy and safety of fondaparinux for the prevention of verous thromboembolism in older acute medical patients’ randomized placebo controlled trailBMJ200633232532916439370
  • CookDAttiaJWeaverBVenous thromboembolic disease: an observational study in medical-surgical intensive care unit patientsJ Crit Care200015412713211138871
  • CoonWWRisk factors in pulmonary embolismSurg Gynecol Obstet19761433385390959958
  • CoubanSGoodyearMBurnellMA Randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer [abstract]Blood100suppl703a Blood 100(Suppl.), 703a. 2002. Ref Type: Abstract
  • CounsellCSandercockPLow-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokeCochrane Database Syst Rev2001no. 4CD00011911687069
  • CummingAMKeeneySSaldenAThe prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic populationBr J Haemato1997982353355
  • DeCMMatovicMBalestreriLAntithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patientsThromb Res19957821271377482430
  • DeCMMatovicMBalestreriLCentral venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective studyThromb Res19978621011139175232
  • denHMRosendaalFRBlomHJHyperhomocysteinemia and venous thrombosis: a meta-analysisThromb Haemost19988068748779869152
  • DickmannUVothESchichaHHeparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhageKlin Wochenschr19886623118211833062268
  • DouketisJDFosterGACrowtherMAClinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapyArch Intern Med2000160223431343611112236
  • DouketisJDGinsbergJSHolbrookAA reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapyArch Intern Med199715714152215309236553
  • DurbecOViviandXPotieFA prospective evaluation of the use of femoral venous catheters in critically ill adultsCrit Care Med1997a2512198619899403747
  • DurbecOViviandXPotieFLower extremity deep vein thrombosis: a prospective, randomized, controlled trial in comatose or sedated patients undergoing femoral vein catheterizationCrit Care Med1997b2512198219859403746
  • ElliottCGZimmermanGAClemmerTPComplications of pulmonary artery catheterization in the care of critically ill patients. A prospective studyChest1979766647652510002
  • EmersonPAMarksPPreventing thromboembolism after myocardial infarction: effect of low-dose heparin or smokingBr Med J1977160521820831965
  • ErelelMCuhadarogluCEceTThe frequency of deep venous thrombosis and pulmonary embolus in acute exacerbation of chronic obstructive pulmonary diseaseRespir Med200296751551812194636
  • FaioniEMValsecchiCPallaAFree protein S deficiency is a risk factor for venous thrombosisThromb Haemost1997785134313469408016
  • FanPYSchwabSJVascular access: concepts for the 1990sJ Am Soc Nephrol1992311111391700
  • FijnheerRHorbachDADondersRCFactor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosusThromb Haemost19967645145178902988
  • FinazzisGBarbuiTDifferent incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein SThromb Haemost199471115188165635
  • FolsomARAleksicNWangLProtein C, antithrombin, and venous thromboembolism incidence: a prospective population-based studyArterioscler Thromb Vasc Biol2002a2261018102212067914
  • FolsomARCushmanMTsaiMYA prospective study of venous thromboembolism in relation to factor V Leiden and related factorsBlood2002b9982720272511929758
  • FraisseFHolzapfelLCoulandJMNadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of FranceAm J Respir Crit Care Med20001614 Pt 11109111410764298
  • FranksALAtrashHKLawsonHWObstetrical pulmonary embolism mortality, United States, 1970–85Am J Public Health19908067207222343959
  • GardlundBRandomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study GroupLancet19963479012135713618637340
  • GatewoodOMFishmanEKBurrowCRRenal vein thrombosis in patients with nephrotic syndrome: CT diagnosisRadiology198615911171223952296
  • GeertsWSelbyRPrevention of venous thromboembolism in the ICUChest20031246 Suppl357S363S14668418
  • GoldbergSKLippmanMLWalkersteinMDThe prevalence of DVT among patients in respiratory failure: the role of DVT prophylaxis [abstract]Am J Respir Crit Care Med1996153SupplA94
  • GoldhaberSZDunnKMacDougallRCNew onset of venous thromboembolism among hospitalized patients at Brigham and Women’s Hospital is caused more often by prophylaxis failure than by withholding treatmentChest200011861680168411115458
  • GoldhaberSZGrodsteinFStampferMJA prospective study of risk factors for pulmonary embolism in womenJAMA199727786426459039882
  • GoldhaberSZKettDHCusumanoCJLow molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: a randomized controlled trial [abstract]J A Coll Cardiol200035suppl325A
  • GoldhaberSZSavageDDGarrisonRJRisk factors for pulmonary embolism. The Framingham StudyAm J Med1983746102310286859053
  • GoldhaberSZTapsonVFA prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosisAm J Cardiol200493225926214715365
  • GolinVSprovieriSRBedrikowRPulmonary thromboembolism: retrospective study of necropsies performed over 24 years in a university hospital in BrazilSao Paulo Med J2002120410510812436156
  • GoodnoughLTSaitoHManniAIncreased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patientsCancer1984547126412686547874
  • GouldJRCarlossHWSkinnerWLGroshong catheter-associated subclavian venous thrombosisAm J Med19939544194238213875
  • GradyDWengerNKHerringtonDPostmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement StudyAnn Intern Med2000132968969610787361
  • GregoryPCKuhlemeierKVPrevalence of venous thromboembolism in acute hemorrhagic and thromboembolic strokeAm J Phys Med Rehabil200382536436912704275
  • HanssonPOErikssonHWelinLSmoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913Arch Intern Med1999159161886189010493318
  • HarenbergJRoebruckPHeeneDLSubcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine GroupHaemostasis19962631271398738587
  • HarenbergJSchomakerUFloshbachCWEnoxaparin is superior to unfractionated heparin in the prevention of thromboembolic events in medical patients at increased thromboembolic risk [abstract]Blood199994suppl.1399a
  • HeatonDCHanDYInderAMinidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosisIntern Med J2002323848811885848
  • HeitJAO’FallonWMPettersonTMRelative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based studyArch Intern Med2002162111245124812038942
  • HeitJASilversteinMDMohrDNRisk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control studyArch Intern Med2000160680981510737280
  • HillarpAZollerBSvenssonPJThe 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosisThromb Haemost19977839909929308741
  • HillbomMErilaTSotaniemiKComparison of the efficacy and safety of the low-molecular-weight heparin enoxaparin with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke [abstract 183a]Blood19999410 Suppl 1183a
  • HirschDRIngenitoEPGoldhaberSZPrevalence of deep venous thrombosis among patients in medical intensive careJAMA199527443353377609264
  • HoarPFWilsonRMManganoDTHeparin bonding reduces thrombogenicity of pulmonary-artery cathetersN Engl J Med1981305179939957024812
  • HoibraatenEAbdelnoorMSandsetPMHormone replace-ment therapy with estradiol and risk of venous thromboembo-lism – a population-based case-control studyThromb Haemost19998241218122110544901
  • HoibraatenEQvigstadEArnesenHIncreased risk of recurrent venous thromboembolism during hormone replacement therapy – results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)Thromb Haemost200084696196711154141
  • HowellMDGeraciJMKnowltonAACongestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control studyJ Clin Epidemiol200154881081611470390
  • HulleySGradyDBushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupJAMA199828076056139718051
  • HulotJSVantelonCUrienSEffect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustmentTher Drug Monit200426330531015167633
  • Ibarra-PerezCLau-CortesEColmenero-ZubiateSPrevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patientsAngiology19883965055133377270
  • IbrahimEHIreguiMPrenticeDDeep vein thrombosis during prolonged mechanical ventilation despite prophylaxisCrit Care Med200230477177411940743
  • IbrahimbachaAAlnajjarNImprovement in the utilization of venous thromboembolism (VTE) prophylaxis in the medical intensive care unit (MICU) [abstract]Chest1998114suppl392S
  • JanssensJPHerrmannFMacGeeWCause of death in older patients with anatomo-pathological evidence of chronic bronchitis or emphysema: a case-control study based on autopsy findingsJ Am Geriatr Soc200149557157611380749
  • JickHJickSSGurewichVRisk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsLancet19953468990158915937500750
  • JimenezRKupferYTesslerSPneumatic stockings do not decresase the incidence of deep venous trhombophlebitis in the critically ill [abstract]Crit Care Med200129suppl12A98 poster 317
  • JoyntGMKewJGomersallCDDeep venous thrombosis caused by femoral venous catheters in critically ill adult patientsChest2000117117818310631217
  • KakkarVVHoweCTNicolaidesANDeep vein thrombosis of the leg. Is there a high risk group?Am J Surg197012045275304097038
  • KamranSIDowneyDRuffRLPneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patientsNeurology1998506168316889633711
  • KapoorMTesslerSKupferYSubcutaneous heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in the critically ill [abstract]Crit Care Med19992712(Suppl.)A69
  • KapurRKMillsLASpitzerSGA prothrombin gene mutation is significantly associated with venous thrombosisArterioscler Thromb Vasc Biol19971711287528799409269
  • KauffmannRHVeltkampJJVan TilburgNHAcquired antithrombin III deficiency and thrombosis in the nephrotic syndromeAm J Med1978654607613707521
  • KayaTIDurHTursenUAssociation of class I HLA antigens with the clinical manifestations of Turkish patients with Behcet’s diseaseClin Exp Dermatol200227649850112372094
  • KemmerenJMAlgraAGrobbeeDEThird generation oral contraceptives and risk of venous thrombosis: meta-analysisBMJ2001323730513113411463678
  • KendallAGLohmannRCDossetorJBNephrotic syndrome. A hypercoagulable stateArch Intern Med19711276102110275578557
  • KerrTMLutterKSMoellerDMUpper extremity venous thrombosis diagnosed by duplex scanningAm J Surg199016022022062382774
  • KierkegaardANorgrenLGraduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarctionEur Heart J19931410136513688262083
  • KierkegaardANorgrenLOlssonCGIncidence of deep vein thrombosis in bedridden non-surgical patientsActa Med Scand198722254094143425393
  • KirazSErtenliIBenekliMClinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic stateLupus19998973774110602446
  • KleberFXWittCVogelGRandomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory diseaseAm Heart J2003145461462112679756
  • KlerkCPSmorenburgSMBullerHRThrombosis prophylaxis in patient populations with a central venous catheter: a systematic reviewArch Intern Med2003163161913192112963564
  • KniffinWDJrBaronJABarrettJThe epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderlyArch Intern Med199415488618668154949
  • KocYGulluIAkpekGVascular involvement in Behcet’s diseaseJ Rheumatol19921934024101578454
  • KoksoyCKuzuAErdenIThe risk factors in central venous catheter-related thrombosisAust N Z J Surg199565117967987487729
  • KosterTRosendaalFRBrietEProtein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)Blood19958510275627617742536
  • KuhlmannUSteurerJRhynerKPlatelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosisClin Nephrol19811552292356166421
  • KuriakosePColon-OteroGPaz-FumagalliRRisk of deep venous thrombosis associated with chest versus arm central venous subcutaneous port catheters: a 5-year single-institution retrospective studyJ Vasc Interv Radiol200213217918411830624
  • LacheradeJCCookDHeylandDPrevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional studyJ Crit Care200318422823714691896
  • LechlerESchrammWFlosbachCWThe venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study GroupHaemostasis199626Suppl (2)49568707167
  • LeizoroviczACohenATTurpieAGRandomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patientsCirculation2004110787487915289368
  • LensenRRosendaalFVandenbrouckeJFactor V Leiden: the venous thrombotic risk in thrombophilic familiesBr J Haematol2000110493994511054086
  • LeroyerCMercierBOgerEPrevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patientsThromb Haemost199880149519684784
  • LeviDKupfterYCereviratnCComputerized order entry sets and intensive education improve the rate of prophylaxis for deep vein thrombophlebitis [abstract]Chest1998114supp280S
  • LevineMNGentMHirshJThe thrombogenic effect of anticancer drug therapy in women with stage II breast cancerN Engl J Med198831874044073340118
  • LewisMAHeinemannLAMacRaeKDThe increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young WomenContraception19965415138804801
  • LidegaardOEdstromBKreinerSOral contraceptives and venous thromboembolism. A case-control studyContraception19985752913019673836
  • LindbladBSternbyNHBergqvistDIncidence of venous thromboembolism verified by necropsy over 30 yearsBMJ199130267787097112021744
  • LlachFHypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndromeKidney Int19852834294393906225
  • LlachFArieffAIMassrySGRenal vein thrombosis and nephrotic syndrome. A prospective study of 36 adult patientsAnn Intern Med19758318141096703
  • LlachFPapperSMassrySGThe clinical spectrum of renal vein thrombosis: acute and chronicAm J Med19806968198277446547
  • LohrJWSchwabSJMinimizing hemorrhagic complications in dialysis patientsJ Am Soc Nephrol1991259619751760540
  • LokichJJBeckerBSubclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancyCancer1983529158615896616416
  • MaderRZivMAdawiMThrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet’s diseaseJ Rheumatol199926112404240810555901
  • MaffeiFHFalleirosATVenezianCAIncidence and pathological anatomy of pulmonary thromboembolism in autopsies (author’s transl)AMB Rev Assoc Med Bras19802617106968934
  • ManganoDTHeparin bonding and long-term protection against thrombogenesisN Engl J Med1982307148948957110267
  • MarikPEAndrewsLMainiBThe incidence of deep venous thrombosis in ICU patientsChest199711136616649118705
  • MartinCViviandXSauxPUpper-extremity deep vein thrombosis after central venous catheterization via the axillary veinCrit Care Med199927122626262910628601
  • MartinelliIMannucciPMDeSVDifferent risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 familiesBlood1998927235323589746774
  • MateoJOliverABorrellMIncreased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study)Blood Coagul Fibrinolysis19989171789607121
  • MazzoneCChiodoGFSandercockPPhysical methods for preventing deep vein thrombosis in strokeCochrane Database Syst Rev2004no. 4CD00192215495020
  • McCarthySTTurnerJLow-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute strokeAge Ageing198615284883962762
  • McCarthySTTurnerJJRobertsonDLow-dose heparin as a prophylaxis against deep-vein thrombosis after acute strokeLancet19772804280080171605
  • MeredithJWYoungJSO’NeilEAFemoral catheters and deep venous thrombosis: a prospective evaluation with venous duplex sonographyJ Trauma19933521871908355295
  • MerrerJDeJBGolliotFComplications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trialJAMA2001286670070711495620
  • MianNZBaylyRSchreckDMIncidence of deep venous thrombosis associated with femoral venous catheterizationAcad Emerg Med1997412111811219408426
  • MiddeldorpSHenkensCMKoopmanMMThe incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosisAnn Intern Med1998128115209424976
  • MiddeldorpSMeinardiJRKoopmanMMA prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolismAnn Intern Med2001135532232711529695
  • MiehslerWReinischWValicEIs inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?Gut200453454254815016749
  • MillerJChanBKNelsonHDPostmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task ForceAnn Intern Med2002136968069011992304
  • MillerRRLiesJECarrettaRFPrevention of lower extremity venous thrombosis by early mobilization. Confirmation in patients with acute myocardial infarction by 125I-fibrinogen uptake and venographyAnn Intern Med1976846700703937882
  • MispelaereDGlerantJCAudebertMPulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensationsRev Mal Respir200219441542312417857
  • MitchellRSWalkerSHSilversGWThe causes of death in chronic airway obstruction. I. The unreliability of death certificates and routine autopsiesAm Rev Respir Dis19689846016105677146
  • MollenholtPErikssonIAnderssonTThrombogenicity of pulmonary-artery cathetersIntensive Care Med198713157593558936
  • MonrealMAlastrueARullMUpper extremity deep venous thrombosis in cancer patients with venous access devices–prophylaxis with a low molecular weight heparin (Fragmin)Thromb Haemost19967522512538815570
  • MonrealMKakkarAKCapriniJAThe outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registryJournal of Thrombosis and Haemostasis20042111892189815550017
  • MonrealMRaventosALermaRPulmonary embolism in patients with upper extremity DVT associated to venous central lines–a prospective studyThromb Haemost19947245485507878630
  • MotykieGDCapriniJAArcelusJIRisk factor assessment in the management of patients with suspected deep venous thrombosisInt Angiol2000191475110853685
  • MuirKWWattABaxterGRandomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute strokeQJM200093635936410873185
  • NickolasTLRadhakrishnanJAppelGBHyperlipidemia and thrombotic complications in patients with membranous nephropathySemin Nephrol200323440641112923730
  • NoelLHZanettiMDrozDLong-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patientsAm J Med19796618290420255
  • OgerEIncidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d’Etude de la Thrombose de Bretagne OccidentaleThromb Haemost200083565766010823257
  • OgerEBressolletteLNonentMHigh prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patientsThromb Haemost2002a88459259712362229
  • OgerELacutKLeGGVanDPIs APC resistance a risk factor for venous thromboembolism in patients over 70 years?Thromb Haemost2002b88458759112362228
  • OgerELeroyerCLeMEThe value of a risk factor analysis in clinically suspected deep venous thrombosisRespiration19976453263309311047
  • OrthSRRitzEThe nephrotic syndromeN Engl J Med199833817120212119554862
  • PabingerIKyrlePAHeistingerMThe risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort studyThromb Haemost19947144414458052960
  • PambiancoGOrchardTLandauPDeep vein thrombosis: prevention in stroke patients during rehabilitationArch Phys Med Rehabil19957643243307717832
  • PerezGSGarcia RodriguezLACastellsagueJHormone replacement therapy and risk of venous thromboembolism: population based case-control studyBMJ199731470837968009081000
  • PinedaLAHathwarVSGrantBJClinical suspicion of fatal pulmonary embolismChest2001120379179511555511
  • PinzonRDrewinkoBTrujilloJMPancreatic carcinoma and Trousseau’s syndrome: experience at a large cancer centerJ Clin Oncol1986445095143958764
  • PittAAndersonSTHabersbergerPGLow dose heparin in the prevention of deep-vein thromboses in patients with acute myocardial infarctionAm Heart J19809955745787369096
  • PoortSRRosendaalFRReitsmaPHA common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosisBlood19968810369837038916933
  • PottierPPlanchonBPistoriusMARisk factors for venous thromboembolism in hospitalized patients in internal medicine: case-control study of 150 patientsRev Med Interne2002231191091812481391
  • PrasadBKBanerjeeAKHowardHIncidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegicsAge Ageing198211142447072559
  • PrescottSMRichardsKLTikoffGVenous thromboembolism in decompensated chronic obstructive pulmonary disease. A prospective studyAm Rev Respir Dis1981123132367458085
  • PrinsMHGelsemaRSingAKProphylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patientsHaemostasis19891952452502550335
  • PritchardKIPatersonAHPaulNAIncreased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site GroupJ Clin Oncol19961410273127378874334
  • RaadIILunaMKhalilSAThe relationship between the thrombotic and infectious complications of central venous cathetersJAMA199427113101410168139059
  • RahimSAPanjuAPaiMVenous thromboembolism prophylaxis in medical inpatients: a retrospective chart reviewThromb Res200311145215219
  • RandolphAGCookDJGonzalesCABenefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trialsChest199811311651719440585
  • RayJGMeta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic diseaseArch Intern Med199815819210121069801176
  • RentschHPThromboembolism complications following acute hemiplegiasSchweiz Med Wochenschr198711747185318553423773
  • RobertAOlmerMSampolJClinical correlation between hypercoagulability and thrombo-embolic phenomenaKidney Int19873138308352437353
  • RochaATMuhlbaierMGovertJVenous Thromboembolism Prophylaxis With Sequential Compression Devices in Critically Ill Medical Patients: Analysis of the Project IMPACT Database [abstract]Chest2003124132Sa
  • RochaATTapsonVFChoice of venous thromboembolic disease prophylaxis in medcial intensive care unit patients [abstract]Chest20021224 (suppl)212S12114328
  • RodeghieroFTosettoAActivated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolismAnn Intern Med1999130864365010215560
  • RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
  • RostokerGDurand-ZaleskiIPetit-PharMPrevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparinNephron199569120287891793
  • RyskampRPTrottierSJUtilization of venous thromboembolism prophylaxis in a medical-surgical ICUChest199811311621649440584
  • SamamaMMAn epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius studyArch Intern Med2000160223415342011112234
  • SamamaMMCohenATDarmonJYA comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study GroupN Engl J Med19993411179380010477777
  • SamuelssonEHaggSIncidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive usersActa Obstet Gynecol Scand200483767468115225194
  • SandercockPAvan den BeltAGLindleyRIAntithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trialsJ Neurol Neurosurg Psychiatry199356117258429318
  • SansonBJSimioniPTormeneDThe incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin protein C, or protein S: a prospective cohort studyBlood199994113702370610572082
  • SaphnerTTormeyDCGrayRVenous and arterial thrombosis in patients who received adjuvant therapy for breast cancerJ Clin Oncol1991922862941988575
  • SarasinFPSchifferliJAProphylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathyKidney Int19944525785858164448
  • ScalaPJThiolletMMidavaineMDeep venous thrombosis and left ventricular thrombosis prophylaxis by low molecular weight heparin in acute myocardial infarctionHaemostasis19902063683691965978
  • ScarabinPYOgerEPlu-BureauDifferential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism riskLancet2003362938242843212927428
  • SchonhoferBKohlerDPrevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary diseaseRespiration19986531731779670296
  • ShustermanNHKlossKMullenJLSuccessful use of double-lumen, silicone rubber catheters for permanent hemodialysis accessKidney Int19893538878902709681
  • SilversteinMDHeitJAMohrDNTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
  • SimioniPSansonBJPrandoniPIncidence of venous thromboembolism in families with inherited thrombophiliaThromb Haemost199981219820210063991
  • SimioniPTormeneDPrandoniPIncidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort studyBlood20029961938194211877263
  • SorensenHTMellemkjaerLSteffensenFHThe risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolismN Engl J Med199833817116911739554856
  • SoutoJCCollILlobetDThe prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish populationThromb Haemost19988033663699759610
  • StrekerudFJohansenAMAbildgaardUVenous thromboembolism – incidence and risk factors in OsloTidsskr Nor Laegeforen199811825393439389830338
  • SuissaSBlaisLSpitzerWOFirst-time use of newer oral contraceptives and the risk of venous thromboembolismContraception19975631411469347203
  • The International Stroke Trial (IST)a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative GroupLancet19973499065156915819174558
  • ThodiyilPAKakkarAKVariation in relative risk of venous thromboembolism in different cancersThromb Haemost20028761076107712083490
  • TimsitJFFarkasJCBoyerJMCentral vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsisChest199811412072139674471
  • TosettoAFrezzatoMRodeghieroFPrevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA ProjectJ Thromb Haemost2003181724172912911584
  • TrewPABiavaCGJacobsRPRenal vein thrombosis in membranous glomerulonephropathy: incidence and associationMedicine (Baltimore)19785716982618442
  • TrottierSJVeremakisCO’BrienJFemoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trialCrit Care Med199523152598001386
  • TveitDPHypoliteIOHshiehPChronic dialysis patients have high risk for pulmonary embolismAm J Kidney Dis20023951011101711979344
  • van BovenHHVandenbrouckeJPBrietEGene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiencyBlood19999482590259410515862
  • Van RoodenCJRosendaalFRMeindersAEThe contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosisHaematologica200489220120615003896
  • VandenbrouckeJPRosingJBloemenkampKWOral contraceptives and the risk of venous thrombosisN Engl J Med2001344201527153511357157
  • VanherweghemJLYassineTGoldmanMSubclavian vein thrombosis: a frequent complication of subclavian vein cannulation for hemodialysisClin Nephrol19862652352383802586
  • VossenCYConardJFontcubertaJFamilial thrombophilia and lifetime risk of venous thrombosisJournal of Thrombosis and Haemostasis2004291526153215333025
  • WagonerRDStansonAWHolleyKERenal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significanceKidney Int19832323683746842962
  • Weill-EngererSMeaumeSLahlouARisk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter studyJ Am Geriatr Soc20045281299130415271117
  • [WHO] World Health OrganisationVenous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone ContraceptionLancet19953468990157515827500748
  • YooHHMendesFGAchados clínicopatológicos na tromboembolia pulmonar: estudo de 24 anos de autópsias*J Bras Pneumol2004305426432
  • ZangariMAnaissieEBarlogieBIncreased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapyBlood20019851614161511520815
  • ZangariMBarlogieBAnaissieEDeep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulationBr J Haematol2004126571572115327525
  • ZawilskaKPsujaPLewandowskiKLow-dose heparin in the prevention of thrombotic complications following acute myocardial infarctionCor Vasa19893131791852670447
  • ZouboulisCCButtnerPTebbeBAnticardiolipin antibodies in Adamantiades-Behcet’s diseaseBr J Dermatol199312832812848471511